
Nebius shares drop 40% despite strong growth; $7B ARR target delayed to Feb 2027, long-term outlook remains positive.
Nebius' stock fell over 40% in a month due to a two-month delay in reaching its $7 billion annual recurring revenue (ARR) target, now expected by February 2027. This delay was caused by third-party provider issues, but the company is improving its da...





